A Potential Blood Test for Diagnosis of Alzheimer’s Disease

Researchers from Saarland University and Siemens Healthcare report that a new blood test can accurately discriminate between healthy people and patients with Alzheimer’s disease. It’s hoped the non-invasive and relatively cheap test could one day help with diagnosis. The research is published in the open access journal Genome Biology [2].

Alzheimer's disease

Some Children Lose Symptoms, Diagnosis of Autism

Some children who are accurately diagnosed in early childhood with autism lose the symptoms and the diagnosis as they grow older, a study supported by the National Institutes of Health has confirmed [1]. The research team made the finding by carefully documenting a prior diagnosis of autism in a small group of school-age children and young adults with no current symptoms of the disorder.


Integrated Diagnostics: Top Innovative Company in Biomedicine

Integrated Diagnostics is one of 10 biomedicine companies included in Technology Review’s 50 Most Innovative Companies (TR50) for 2012 [1].

Integrated Diagnostics

Foundation Medicine: Top Innovative Company in Biomedicine

Foundation Medicine is one of 10 biomedicine companies included in Technology Review’s 50 Most Innovative Companies (TR50) for 2012 [1].

Foundation Medicine

Biomarker Bulletin: June 20, 2011

Biomarker Bulletin is an occasionally recurring update of news focused on biomarkers aggregated at BiomarkerCommons.org. Biomarkers are physical, functional or biochemical indicators of normal physiological or disease processes. The individualization of disease management — personalized medicine — is dependent on developing biomarkers that promote specific clinical domains, including early detection, risk, diagnosis, prognosis and predicted response to therapy.

Biomarker Commons

  • Results of Highly Cited Biomarker-disease Associations Often Overestimated

    Although new biomarkers are regularly proposed to serve as potential determinants of disease risk, prognosis or response to treatment, many markers only get evaluated in one or a small number of studies. A review in the June 1st edition of JAMA reports that the results of highly cited biomarker-disease associations that appear in major journals are often substantially overestimated, with effect sizes exceeding those found when the association is evaluated in larger studies.

  • Roche, UCLA Announce Biomarker Research Collaboration

    Roche said last week that it will provide UCLA scientists with a range of genomics tools as part of a research collaboration to study stem cells and cancer, and for the development of new predictive biomarkers for future therapeutics and diagnostics for a host of diseases.

  • Stemina Biomarker Discovery, Children’s Hospital of Orange County Sign Agreement to Study Autism

    Stemina Biomarker Discovery announced on Friday that it has signed an agreement with Children’s Hospital of Orange County (CHOC) to conduct a study of neural cells from autistic patients using Stemina’s proprietary biomarker discovery platform.

  • Indiana CTSI, GVK Biosciences Partner to Provide National Access to Biomarkers Database

    The Indiana Clinical and Translational Sciences Institute (CTSI), a statewide collaboration of Indiana University, Purdue University and the University of Notre Dame, as well as public and private partnerships, which facilitates the translation of scientific discoveries in the lab into clinical trials and new patient treatments in Indiana and beyond, announced on Friday that they have partnered with GVK Biosciences. GVK Biosciences will provide researchers across the United States access to their clinical biomarker database.

  • Biomarker Briefs: June 13, 2011

    Biomarker Briefs is an occasionally recurring series highlighting particularly interesting articles on biomarkers and/or personalized medicine. This edition includes articles on personalized medicine, a new online tool for analyzing personal genome data, a blood test for depression, and a kidney injury biomarker initiative.